Effect of erythropoietin on kidney allograft survival, early use after transplantation

Iranian Journal of Kidney Diseases

Volumn 6, Issue 1, 2012, Pages 44-48

  Yasari, Fatemeh ^a   Nafar, Mohsen ^a,b   Abdei, Behrang Alipour ^a   Ahmadpoor, Pedram ^a,b   Pour Reza Gholi, Fatemeh ^a,b   Samadian, Fariba ^a,b   Farhangi, Soudabeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anemia; Erythropoietin; Kidney transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; ERYTHROPOIETIN; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PD POIETIN; PLACEBO; PREDNISOLONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EARLY INTERVENTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MORTALITY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TISSUE OXYGENATION; TREATMENT OUTCOME;

EID: 84855544551     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Montanaro D. [Anemia after renal transplantation]. G Ital Nefrol. 2007;24:13-22. Italian.
2. Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Goldsmith D. Anemia after renal transplantation. Am J Kidney Dis. 2006;48:519-36.
3. Keogh CL, Yu SP, Wei L. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther. 2007;322:521-8.
4. Ben-Dor I, Hardy B, Fuchs S, et al. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model. Cardiovasc Drugs Ther. 2007;21:339-46.
5. van Albada ME, du Marchie Sarvaas GJ, Koster J, Houwertjes MC, Berger RM, Schoemaker RG. Effects of erythropoietin on advanced pulmonary vascular remodeling. Eur Respir J. 2008;31:126-34.
6. Palazzuoli A, Silverberg DS, Iovine F, et al. Effects of betaerythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J. 2007;154:645.e9-15.
7. Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38:2795-803.
8. Keogh CL, Yu SP, Wei L. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther. 2007;322:521-8.
9. Satoh K, Kagaya Y, Nakano M, et al. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation. 2006;113:1442-50.
10. Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke. 2007;38:2795-803.
11. Ben-Dor I, Hardy B, Fuchs S, et al. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model. Cardiovasc Drugs Ther. 2007;21:339-46.
12. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int. 2000;58:647-57.
13. Joneja B, Wojchowski DM. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain. J Biol Chem. 1997;272:11176-84.
14. Li Y, Takemura G, Okada H, et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res. 2006;71:684-94.
15. Minamito T, Kitakaze M. New therapeutic application of erythropoietin against ischemic heart diseases. J Pharmacol Sci. 2006;101:179-81.
16. Nishiya D, Omura T, Shimada K, et al. Effects of erythropoietin on cardiac remodeling after myocardial infarction. J Pharmacol Sci. 2006;101:31-9.
17. Miki T, Miura T, Yano T, et al. Alteration in erythropoietininduced cardioprotective signaling by postinfarct ventricular remodeling. J Pharmacol Exp Ther. 2006;317:68-75.
18. Kozlovskaia LV, Milovanov IuS, Nikolaev AIu, Milovanova LIu. Erythropoetin and iron preparations in the treatment of anemia in patients with chronic kidney disease of stage III-IV in systemic diseases. Ter Arkh. 2007;79:30-4.
19. Schwenger V, Morath C, Zeier M. Use of erythropoietin after solid organ transplantation. Nephrol Dial Transplant. 2007;22:viii 47-9.
20. Moon C, Krawczyk M, Ahn D, et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA. 2003;100:11612-7.
21. Gleissner CA, Murat A, Schafer S, et al. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function. Transplantation. 2004;77:710-7.
22. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-9.
23. Sepodes B, Maio R, Pinto R, et al. Recombinant human erythropoietin protects the liver from hepatic ischemiareperfusion injury in the rat. Transpl Int. 2006;19:919-26.
24. Gleissner CA, Klingenberg R, Staritz P, et al. Role of erythropoietin in anemia after heart transplantation. Int J Cardiol. 2006;112:341-7.
25. Layon ME, Ackley CJ, West RJ, Lowrey CH. Expression of GATA-1 in a non-hematopoietic cell line induces betaglobin locus control region chromatin structure remodeling and an erythroid pattern of gene expression. J Mol Biol. 2007;366:737-44.
26. Baltar J, Moran N, Ortega F, et al. Erythropoietin safety and efficacy in chronic allograft nephropathy. Transplant Proc. 2007;39:2245-7.
27. Molina P, Gavela E, Sancho A, et al. Erythropoietin treatment in the sixth posttransplant month as a prognostic factor for renal allograft survival. Transplant Proc. 2006;38:2441-4.
28. Lietz K, Lao M, Paczek L, Górski A, Gaciong Z. The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation. Ann Transplant. 2003;8:17-24.